IFP Advisors’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-4,250
| Closed | – | – | 4644 |
|
|
2021
Q4 | $0 | Hold |
4,250
| – | – | ﹤0.01% | 3567 |
|
|
2021
Q3 | $0 | Hold |
4,250
| – | – | ﹤0.01% | 3526 |
|
|
2021
Q2 | $0 | Hold |
4,250
| – | – | ﹤0.01% | 3352 |
|
|
2021
Q1 | $0 | Hold |
4,250
| – | – | ﹤0.01% | 3341 |
|
|
2020
Q4 | $0 | Sell |
4,250
-4,000
| -48% | – | ﹤0.01% | 3217 |
|
|
2020
Q3 | $0 | Hold |
8,250
| – | – | ﹤0.01% | 3109 |
|
|
2020
Q2 | $0 | Hold |
8,250
| – | – | ﹤0.01% | 3081 |
|
|
2020
Q1 | $0 | Buy |
+8,250
| New | – | ﹤0.01% | 3140 |
|
|
2019
Q1 | $0 | Sell |
4,000
-2,000
| -33% | -$509 | ﹤0.01% | 3880 |
|
|
2018
Q4 | $1K | Sell |
6,000
-200
| -3% | -$131 | ﹤0.01% | 3474 |
|
|
2018
Q3 | $11K | Hold |
6,200
| – | – | ﹤0.01% | 2834 |
|
|
2018
Q2 | $11K | Buy |
6,200
+1,380
| +29% | +$2.39K | ﹤0.01% | 2869 |
|
|
2018
Q1 | $11K | Hold |
4,820
| – | – | ﹤0.01% | 2765 |
|
|
2017
Q4 | $11K | Sell |
4,820
-635
| -12% | -$1.58K | ﹤0.01% | 2806 |
|
|
2017
Q3 | $16K | Hold |
5,455
| – | – | ﹤0.01% | 2771 |
|
|
2017
Q2 | $24K | Sell |
5,455
-1,200
| -18% | -$4.95K | ﹤0.01% | 2486 |
|
|
2017
Q1 | $31K | Buy |
6,655
+4,255
| +177% | +$24.7K | ﹤0.01% | 2231 |
|
|
2016
Q4 | $15K | Buy |
2,400
+700
| +41% | +$3.66K | ﹤0.01% | 2680 |
|
|
2016
Q3 | $9K | Sell |
1,700
-2,530
| -60% | -$11.8K | ﹤0.01% | 2931 |
|
|
2016
Q2 | $16K | Buy |
4,230
+230
| +6% | +$780 | ﹤0.01% | 2510 |
|
|
2016
Q1 | $0 | Buy |
4,000
+3,288
| +462% | +$11.9K | ﹤0.01% | 3860 |
|
|
2015
Q4 | $4K | Buy |
+712
| New | +$4.34K | ﹤0.01% | 3127 |
|
IFP Advisors's SGYP Position: Q1 2022 in Review
IFP Advisors sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q1 2022, closing a stake of 4,250 shares.
IFP Advisors first reported a position in SGYP in Q4 2015 and held it in 22 quarters. The position peaked at $31K in Q1 2017. 2 funds tracked by Wall St. Rank hold SGYP as of Q1 2022.
- IFP Advisors reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q1 2022 after selling out during the quarter.
- IFP Advisors sold 4,250 Synergy Pharmaceuticals, Inc Common Stock shares in Q1 2022.
- IFP Advisors first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q4 2015 and held it in 22 quarters.
- IFP Advisors's Synergy Pharmaceuticals, Inc Common Stock position peaked at $31K in Q1 2017.
- 2 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q1 2022.
Based on IFP Advisors's 13F filing for Q1 2022, filed 8 Aug 2022.